About this trial
Numerous clinical studies have highlighted the role of macrophages in the destabilization of coronary lesions; however, there is limited literature on the relationship between circulating monocytes and intraplaque macrophages.
This study aims to evaluate and compare the presence of macrophages and their subsequent activation within coronary and peripheral atherosclerotic lesions, and to correlate these findings with the distribution of circulating monocyte subpopulations.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients with chronic coronary artery disease;
Patients with no-ST elevation acute coronary syndrome;
Patients with chronic claudication (Rutherford II-III)
Patients with critical limb ischemia (Rutherford IV-V).
Disqualifiers
Severe renal dysfunction
Severe valve disease
Advanced heart failure
Advanced liver disease
Trial design
Parallel
Treatments tested in this trial
Optical Coherence Tomography assessment
Diagnostic testassessment of the number of infiltrating macrophages
Treatment groups
Trial outcomes
Primary outcomes
presence of macrophages and their activation within coronary and peripheral atherosclerotic lesions
To evaluate and compare the presence of macrophages and their subsequent activation within coronary and peripheral atherosclerotic lesions (using OCT imaging), and to correlate these findings with the distribution of circulating monocyte subpopulations.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.